Statin Savings: New Generic Options Could Boost Brand Switches, Cut Costs For Medicare
This article was originally published in The Pink Sheet Daily
Introduction of new, more effective generic statins could yield $8.2 bil. for Medicare benefit in 2007, Consumers Union report says.
You may also be interested in...
Trade group welcomes greater scrutiny of drugs' effectiveness, but emphasizes that decisions should remain in the hands of PBMs.
Agency may share outcomes of remote record reviews in lieu of inspections at US and foreign facilities.